A phase 1/2, first-in-human study of STX-478 monotherapy or in combination with fulvestrant in patients with breast cancer or other advanced solid tumors (trial in progress)

被引：0
|
作者：
Montero, Alberto
Orr, Douglas
Munster, Pamela
LoRusso, Patricia
Jhaveri, Komal
Pluard, Timothy
Winer, Ira
Streit, Michael
Patterson, Monica
Roberts, Simon
Corsi-Travali, Stefani
Ewert, Courtney
Juric, Dejan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-20-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-20-04
引用
收藏
页数：4
相关论文
共 50 条
  • [41] ONCX-NAV-G201: A phase 2, basket study of navicixizumab monotherapy or in combination with chemotherapy in patients with select advanced solid tumors: Triple-negative breast cancer cohort (trial in progress)
    Zelnak, Amelia B.
    Lenz, Heinz-Josef
    Culm, Kerry
    Makris, Lukas
    Santos, Valerie Chamberlain
    Youssoufian, Hagop
    Mockbee, Colleen
    Miller, Kathy D.
    CANCER RESEARCH, 2023, 83 (05)
  • [42] First-in-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors
    Smith, Barry H.
    Parikh, Tapan
    Andrada, Zoe P.
    Fahey, Thomas J.
    Berman, Nathaniel
    Wiles, Madeline
    Nazarian, Angelica
    Thomas, Joanne
    Arreglado, Anna
    Akahoho, Eugene
    Wolf, David J.
    Levine, Daniel M.
    Parker, Thomas S.
    Gazda, Lawrence S.
    Ocean, Allyson J.
    CANCER GROWTH AND METASTASIS, 2016, 9
  • [43] A FIRST-IN-HUMAN, MULTICENTER, PHASE 1/2, OPEN-LABEL STUDY OF XTX101 IN PATIENTS WITH ADVANCED SOLID TUMORS
    Powderly, John
    Norman, Teleen
    Duncan, Meghan
    Huber, Martin
    O'Neil, Jennifer
    Patel, Ekta
    Vandross, Andrae
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A549 - A549
  • [44] First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors
    Elena Elez, Maria
    Tabernero, Josep
    Geary, David
    Macarulla, Teresa
    Kang, S. Peter
    Kahatt, Carmen
    Soto-Matos Pita, Arturo
    Fernandez Teruel, Carlos
    Siguero, Mariano
    Cullell-Young, Martin
    Szyldergemajn, Sergio
    Ratain, Mark J.
    CLINICAL CANCER RESEARCH, 2014, 20 (08) : 2205 - 2214
  • [45] A phase I, first-in-human study of DS-1471 in patients with advanced/metastatic solid tumors
    Koganemaru, S.
    Yoshizuka, N.
    Mizuno, S.
    Hirai, S.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S531 - S531
  • [46] Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors
    Balmana, J.
    Tung, N. M.
    Isakoff, S. J.
    Grana, B.
    Ryan, P. D.
    Saura, C.
    Lowe, E. S.
    Frewer, P.
    Winer, E.
    Baselga, J.
    Garber, J. E.
    ANNALS OF ONCOLOGY, 2014, 25 (08) : 1656 - 1663
  • [47] First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Yoh, Kiyotaka
    Shitara, Kohei
    Takahashi, Hideaki
    Ueno, Makoto
    Kobayashi, Satoshi
    Morimoto, Manabu
    Okusaka, Takuji
    Ueno, Hideki
    Morizane, Chigusa
    Okano, Naohiro
    Nagashima, Fumio
    Furuse, Junji
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 507 - 518
  • [48] First-in-human phase I trial of NHS-IL12 in advanced solid tumors
    Kim, Joseph W.
    Heery, Christopher Ryan
    Bilusic, Marijo
    Singh, Nishith K.
    Madan, Ravi A.
    Sabzevari, Helen
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors
    Toshihiko Doi
    Kiyotaka Yoh
    Kohei Shitara
    Hideaki Takahashi
    Makoto Ueno
    Satoshi Kobayashi
    Manabu Morimoto
    Takuji Okusaka
    Hideki Ueno
    Chigusa Morizane
    Naohiro Okano
    Fumio Nagashima
    Junji Furuse
    Investigational New Drugs, 2019, 37 : 507 - 518
  • [50] TRIAL IN PROGRESS: A PHASE 1 FIRST-IN-HUMAN STUDY OF HMBD-002, AN IGG4 MONOCLONAL ANTIBODY TARGETING VISTA, AS A MONOTHERAPY AND COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES
    Haber, Tom
    Symons, Jessica
    Dharmadhikari, Bhushan
    Mueller, Thomas
    Thakkar, Dipti
    Rodon, Jordi Ahnert
    Gruber, Joshua
    Telli, Melinda
    Mita, Monica
    Mita, Alain
    Patel, Meera
    Wang, Daniel
    Kim, Joseph
    Yadav, Shalini
    Sharma, Padmanee
    DiMascio, Leah
    Rowinsky, Eric
    Ingram, Piers
    Boyd-Kirkup, Jerome
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A655 - A655
12345